Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by canadapieton Apr 13, 2023 5:04pm
67 Views
Post# 35393980

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Eurk!

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Eurk!

You lost the way man,allready a long time!!!
Don't understand why you keep on defending that "desastrous" management. 
Of course they will do everything to keep on going, look at their remuneration + options without the risk a shareholder has....!!!!! 

Ridiculous, laughable, even criminal????

 

SPCEO1 wrote:While you are correct  they cannot know 100% in advance if TH-1902 will succeed, they do have some expectation of success or they would not be bothering to proceed. So, the question then becomes what percentage chance of success is high enough to justify the board's effort to keep the management team that brought TH-1902 close to a first level of success in place at a high cost? It seems to me the  board must think there is a pretty high chance of success or they would not have given out those big option grants and bonuses. That is the positive and bulish interpretation of this compensation info. Hopefully, it is the correct interpretation and not just another fleecing of shareholders which is sadly not atypical in the corprate sector. 

If I have accurately discerned that this is what the board is actually doing, they probably should communicate that to shareholders before people start voting. It is in their own best interests as well as ours.

<< Previous
Bullboard Posts
Next >>